SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000069499-13-000036
Filing Date
2013-08-01
Accepted
2013-08-01 17:07:18
Documents
10
Period of Report
2013-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q myl10q_20130630xdoc.htm 10-Q 1749049
2 EX-31.1 myl_ex311x20130630-10q.htm EX-31.1 9187
3 EX-31.2 myl_ex312x20130630-10q.htm EX-31.2 9329
4 EX-32 myl_ex32x20130630-10q.htm EX-32 8969
  Complete submission text file 0000069499-13-000036.txt   21188471

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT myl-20130630.xml EX-101.INS 2966347
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT myl-20130630.xsd EX-101.SCH 62594
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT myl-20130630_cal.xml EX-101.CAL 109161
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT myl-20130630_def.xml EX-101.DEF 474694
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT myl-20130630_lab.xml EX-101.LAB 847969
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT myl-20130630_pre.xml EX-101.PRE 575652
Mailing Address 1500 CORPORATE DRIVE CANONSBURG PA 15317
Business Address 1500 CORPORATE DRIVE CANONSBURG PA 15317 724-514-1800
MYLAN INC. (Filer) CIK: 0000069499 (see all company filings)

IRS No.: 251211621 | State of Incorp.: PA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-09114 | Film No.: 131003412
SIC: 2834 Pharmaceutical Preparations